Picture of ANI Pharmaceuticals logo

ANIP ANI Pharmaceuticals Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual income statement for ANI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue202207208216316
Cost of Revenue
Gross Profit129143121116178
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses166190224256352
Operating Profit35.416.4-16-39.8-35.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes20.13.16-26-56.1-62.7
Provision for Income Taxes
Net Income After Taxes15.56.09-22.5-42.6-47.9
Net Income Before Extraordinary Items
Net Income15.56.09-22.5-42.6-47.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income15.36-22.5-42.8-49.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.30.864-1.25-2.78-2.81

Or unlock with your email

Or unlock with your email